2025-524434-25-00招募中2 期
"Contribution of 68Ga-FAPI-46 PET-CT in the initial staging of gastric cancers eligible for curative treatment" "FAPGASTRO"
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 40
- 试验地点
- 2
研究概览
简要总结
In the study target population (stage ≥ II gastric adenocarcinomas or signet-ring cells adenocarcinomas of any stage, eligible for curative treatment), estimate the proportion of patients who present an appropriate change of TNM classification following the addition of 68Ga-FAPI-46 PET-CT to the reference examinations, during the initial staging (including laparoscopy)
入排标准
- 年龄范围
- 18 years 至 65+ years（65+ Years, 18-64 Years）
- 接受健康志愿者
- 否
入选标准
- •Gastric cancer: stage ≥ II gastric adenocarcinoma or signet-ring cell adenocarcinoma whatever the stage, potentially requiring curative treatment
- •Age > 18 years old at time of signed consent
- •Beneficiary of social security insurance
- •Signed informed consent by the participant and the investigator
排除标准
- •Tumor M+ or with suspicion of distant metastasis on standard assessment
- •Person deprived of liberty by judicial or administrative decision
- •Neoadjuvant treatment already started
- •History of other active cancer
- •Known contraindication to a PET examination with injection of radiopharmaceuticals (hypersensitivity to the radiopharmaceutical drug and/or excipients)
- •Pregnant or breastfeeding woman
- •Woman of childbearing capacity and not benefiting from effective contraception (HAS criterion)
- •Person subject to a legal protection measure or unable to personally give consent
- •Person in an emergency situation
- •Exclusion period from another protocol
研究者
Ghoufrane TLILI
Scientific
Centre Hospitalier Universitaire De Bordeaux
研究点 (2)
Loading locations...
相似试验
招募中
2 期
Role of [68Ga]Ga-FAPI PET/CT in oncological patients with doubtful or inconclusive findings at [18F]F-FDG PET/CT2024-518765-96-00Azienda Ospedaliero-Universitaria Di Bologna IRCCS Istituto Di Ricerca E Di Cura A Carattere Scientifico200
招募中
1 期
ProspectivE phase 0 pilot study, assessing potential prognostic and theranostic interest of 68Ga-PentiXafor PET-CT In metastatic triple neGative brEast caNCer patiEnts (EXIGENCE)triple-negative breast cancer2024-517658-90-00Institut De Cancerologie De L Ouest12
Unknown
不适用
FAP 靶向探针 18F/68Ga-FAPI 在实体肿瘤中的 PET 显像研究ChiCTR2500111549自选课题（自筹）
招募中
1 期
Application of [68Ga]Ga-NI-FAPI-04 PET/CT Imaging in Fibroblast Activation Protein Related DiseasesPulmonary FibrosisTumorNCT07464132Peking Union Medical College Hospital30
招募中
2 期
[68Ga]Ga-FAPI total body PET/CT for improving diagnostic sensitivity and preoperative staging in gastroesophageal cancer and pancreatic cancer2023-503632-41-01Rigshospitalet